Immune Phenotype and Response to Neoadjuvant Therapy in Triple-Negative Breast Cancer

Author:

Yam Clinton,Yen Er-YenORCID,Chang Jeffrey T.,Bassett Roland L.,Alatrash Gheath,Garber HavenORCID,Huo Lei,Yang FeiORCID,Philips Anne V.,Ding Qing-Qing,Lim BoraORCID,Ueno Naoto T.ORCID,Kannan Kasthuri,Sun Xiangjie,Sun Baohua,Parra Cuentas Edwin RogerORCID,Symmans William FraserORCID,White Jason B.ORCID,Ravenberg Elizabeth,Seth SahilORCID,Guerriero Jennifer L.ORCID,Rauch Gaiane M.ORCID,Damodaran Senthil,Litton Jennifer K.,Wargo Jennifer A.,Hortobagyi Gabriel N.ORCID,Futreal Andrew,Wistuba Ignacio I.,Sun Ryan,Moulder Stacy L.,Mittendorf Elizabeth A.

Funder

2020 Conquer Cancer Career Development Award

Fleur Fairman

2018 Gianni Bonadonna Breast Cancer Research Fellowship

Conquer Cancer Foundation

Winterhoff fund

Pink Ribbons Project

Nancy Owens Memorial Foundation

NIH

NCI Cancer Center Support Grant

Amgen Inc.

Astellas Pharma Global Development, Inc.

Genentech, USA Inc.

Novartis AG

Pfizer Inc

Allison and Brian Grove Endowed Fellowship

Cancer Prevention Research Institute of Texas

NIH's NCI

Rob and Karen Hale Distinguished Chair in Surgical Oncology

Ludwig Center at Harvard

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3